Trial Details
COMPLETEDBasic Information
| Clinical ID | c4675 |
|---|---|
| Identifier | NCT00152490 |
| Trial Title | A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Certolizumab Pegol (CDP870) |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2003-12 |
|---|---|
| Primary Completion Date | 2005-05 |
| Completion Date | 2005-05 |